15 Jul 2015 05:18
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
BTG Share News (BTG)
BTG Share
Price
BTG Share
News
BTG Share
Chat
BTG Share
Trades
BTG
Live RNS
BTG Share
Charts
BTG Broker
Ratings
BTG Directors
Deals
BTG Financial
Diary
BTG
Fundamentals
BTG Short
Positions
BTG
Media
BTG Information
- There is currently no data for BTG
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Monday broker round-up
Mon, 17th Sep 2018 15:10
(Sharecast News) - Sophos: Deutsche Bank downgrades to hold with a target price of 530p.Tesco: Berenberg reiterates buy with a target price of 295p.Sainsbury: Berenberg reiterates buy with a target price of 369p.Morrison: Berenberg reiterates hold with a target price of 250p.BTG: Deutsche Bank reiterates hold with a target price of 645p.Prudential: Morgan Stanley reiterates overweight with a target price of 2,469p.Dairy Crest: Numis reiterates buy with a target price of 590p.Wetherspoon: Numis reiterates reduce with a target price of 1,060p.Tullow Oil: Canaccord upgrades to buy with a target price of 270p.W Resources: Northland Capital Markets reiterates buy with a target price of 1.2p.Avon Rubber: Berenberg reiterates buy with a target price of 1,715p.
More News
14 Jul 2015 14:59
14 Jul 2015 05:18
13 Jul 2015 15:07
13 Jul 2015 05:17
10 Jul 2015 16:11
10 Jul 2015 05:17
9 Jul 2015 15:21
9 Jul 2015 05:23
8 Jul 2015 15:20
29 Jun 2015 14:51
Investec affirms 'buy' rating for BTG, confident about varicose vein treatment
Investec reiterated a 'buy' rating and price target of 647p for pharmaceuticals firm BTG after reappraising its key product Varithena. The bank said investors overreacted to concerns over BTG's earning profile, in particular the varicose vein treatment Varithena. "After interviewing physicians and
Read more